Evaluating the effect of long-term idebenone treatment on respiratory morbidity in patients with Duchenne muscular dystrophy (DMD)

被引：3
|
作者：
Mayer, Oscar Henry [1 ]
Leinonen, Mika [2 ]
Servais, Laurent [3 ]
Straathof, Chiara [4 ]
Schara, Ulrike [5 ]
Voit, Thomas [6 ]
Mercuri, Eugenio [7 ]
Buyse, Gunnar [8 ]
机构：
[1] Childrens Hosp Philadelphia, Philadelphia, PA 19104 USA
[2] Santhera Pharmaceut, Pratteln, Switzerland
[3] CHU Liege, Ctr Reference Neuromusculaire, Liege, Belgium
[4] Leiden Univ, Med Ctr, Leiden, Netherlands
[5] Univ Klinikum Essen, Zentrum Kinderheilikunde Sozialpadiatr Zentrum, Essen, Germany
[6] UCL Great Ormond St Inst Child Hlth, NIHR Great Ormond St Hosp Biomed Res Ctr, London, England
[7] Catholic Univ, Paediat Neurol Unit, Rome, Italy
[8] Univ Hosp Leuven, Leuven, Belgium
来源：
EUROPEAN RESPIRATORY JOURNAL | 2019年 / 54卷
关键词：
Neuromuscular diseases;
D O I：
10.1183/13993003.congress-2019.OA5330
中图分类号：
R56 [呼吸系及胸部疾病];
学科分类号：
摘要：
OA5330
引用
收藏
页数：2
相关论文
共 50 条
  • [31] Long-term effect of ataluren in fourteen patients with nonsense mutation Duchenne muscular dystrophy
    Ortez, C.
    Medina, J.
    Vigo, M.
    Moya, O.
    Padros, N.
    Natera De Benito, D.
    Carrera, L.
    Colomer, J.
    Zschaeck, I.
    Jimenez-Mallebrera, C.
    Sole, L.
    Cubells, M.
    Jou, C.
    Nascimento, A.
    NEUROMUSCULAR DISORDERS, 2018, 28 : S63 - S63
  • [32] Glucocorticoids influence therapeutic efficacy of idebenone (Catena®) on peak expiratory flow in patients with Duchenne muscular dystrophy (DMD)
    Buyse, G. M.
    Goemans, N.
    van den Hauwe, M.
    de Groot, I. J. M.
    Schara, U.
    Ceulemans, B.
    Meier, T.
    NEUROMUSCULAR DISORDERS, 2009, 19 (8-9) : 610 - 610
  • [33] Bone density in patients with Duchenne muscular dystrophy (DMD)
    Eagle, M
    Rawlings, D
    Straub, V
    Bushby, K
    NEUROMUSCULAR DISORDERS, 2005, 15 (9-10) : 689 - 689
  • [34] Results of a Long-Term Efficacy and Safety Study of Viltolarsen in the Treatment of Duchenne Muscular Dystrophy Patients
    Rao, V
    Clemens, P.
    Connolly, A.
    Harper, A.
    Mah, J.
    Smith, E.
    McDonald, C.
    Zaidman, C.
    Nakagawa, T.
    Hoffman, E.
    ANNALS OF NEUROLOGY, 2021, 90 : S92 - S92
  • [35] Effect of idebenone on bronchopulmonary adverse events and hospitalizations in patients with Duchene muscular dystrophy (DMD)
    Lawrence, C.
    Wamock, A.
    McDonald, C.
    Mayer, O.
    Meier, T.
    Leinonen, M.
    Buyse, G.
    NEUROMUSCULAR DISORDERS, 2018, 28 : S16 - S17
  • [36] Effect Of Idebenone On Bronchopulmonary Adverse Events And Hospitalizations In Patients With Duchene Muscular Dystrophy (dmd)
    Mayer, O.
    McDonald, C.
    Meier, T.
    Leinonen, M.
    Buyse, G.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2017, 195
  • [37] Long term growth hormone therapy in Duchenne Muscular Dystrophy (DMD): A case report
    Lee, H. N.
    Rose, S. R.
    Rutter, M. M.
    Sawnani, H.
    Ryan, T.
    Rybalsky, I.
    Wong, B. L.
    NEUROMUSCULAR DISORDERS, 2013, 23 (9-10) : 754 - 755
  • [38] Longitudinal assessment of respiratory function in Duchenne muscular dystrophy (DMD): The effect of steroid therapy
    LoMauro, Antonella
    Romei, Marianna
    Gandossini, Sandra
    D'Angelo, Maria Grazia
    Aliverti, Andrea
    EUROPEAN RESPIRATORY JOURNAL, 2014, 44
  • [39] Design of an international phase III study with idebenone (Catena®) in patients with Duchenne muscular dystrophy (DMD) - The DELOS study
    Buyse, G. M.
    Meier, T.
    Finkel, R. S.
    NEUROMUSCULAR DISORDERS, 2009, 19 (8-9) : 612 - 612
  • [40] Orthopedic outcomes of long-term daily corticosteroid treatment in Duchenne muscular dystrophy
    King, W. M.
    Ruttencutter, R.
    Nagaraja, H. N.
    Matkovic, V.
    Landoll, J.
    Hoyle, C.
    Mendell, J. R.
    Kissel, J. T.
    NEUROLOGY, 2007, 68 (19) : 1607 - 1613
12345